EpCAM is overexpressed in various epithelial cancers [16] and is an ideal therapeutic target because of the following reasons: (a) overexpression in cancer cells versus noncancerous cells, (b) apical expression in cancer cells and basolateral expression in normal epithelial cells [17], and (c) not shed into the circulation [18]. Here, EPCAM is linked to cancer.